×
About 8,516 results

ALLMedicine™ Allergic Asthma Center

Research & Reviews  4,229 results

Dexamethasone-loaded H2O2-activatable anti-inflammatory nanoparticles for on-demand the...
https://doi.org/10.1016/j.nano.2020.102301
Nanomedicine : Nanotechnology, Biology, and Medicine; Lee H, Jeong SW et. al.

Sep 17th, 2020 - Asthma is a common airway inflammatory disorder, characterized by increased infiltration of leukocytes and bronchoconstriction. Dexamethasone (DEX) has been widely used in the treatment of allergic asthma. However, long-term and frequent use of DE...

Biflavonoid-rich fraction from Daphne pseudomezereum var. koreana Hamaya exerts anti-in...
https://doi.org/10.1016/j.jep.2020.113386
Journal of Ethnopharmacology; Lee JW, Ryu HW et. al.

Sep 13th, 2020 - Daphne pseudomezereum var. koreana Hamaya is distributed in the Gangwon-do of South Korea and is traditionally used to treat chronic inflammatory diseases, including rheumatoid arthritis. We investigated the anti-inflammatory effect of biflavonoid...

A Novel Mutation in the IL6R Gene Identified in a Family with Asthma Patients.
https://doi.org/10.1089/gtmb.2020.0081
Genetic Testing and Molecular Biomarkers; Trueb B, Zhuang L et. al.

Sep 10th, 2020 - Background: Allergic diseases, including asthma, atopic dermatitis, allergic rhinitis, and food allergies, are caused by both environmental and genetic factors. The allergic condition, where genetic factors make up the largest proportion (up to 95...

IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism and ...
https://doi.org/10.1016/j.jaci.2020.08.024
The Journal of Allergy and Clinical Immunology; Howard E, Lewis G et. al.

Sep 9th, 2020 - ILC2s are the dominant innate lymphoid cell population in the lungs at steady state and their release of type 2 cytokines is a central driver in responding eosinophil infiltration and increased airway hyperreactivity (AHR). Our laboratory has iden...

Vagal-α7nAChR signalling attenuates allergic asthma responses and facilitates asthma to...
https://doi.org/10.1111/imcb.12400
Immunology and Cell Biology; Feng X, Li L et. al.

Sep 7th, 2020 - Disorders of immune tolerance may lead to allergic asthma. Innate lymphoid cells (ILC2s) and inflammatory ILC2s (iILC2s) are key players in asthma. The vagus nerve innervating the airways releases acetylcholine (ACh) or neuropeptides (i.e. CGRP) v...

see more →

Guidelines  2 results

Eosinophilic Asthma | Apfed
https://apfed.org/about-ead/eosinophilic-asthma/

Jun 25th, 2018 - For decades physicians have understood that a diagnosis of asthma requires further description because attacks of wheezing and shortness of breath can be associated with several underlying diseases. For example, patients allergic to animal dander,...

Recommendations for the standardization of clinical outcomes used in allergen immunothe...
https://doi.org/10.1111/all.12383
Allergy Pfaar O, Demoly P et. al.

Apr 25th, 2014 - Allergen immunotherapy (AIT) has been thoroughly documented in randomized controlled trials (RCTs). It is the only immune-modifying and causal treatment available for patients suffering from IgE-mediated diseases such as allergic rhinoconjunctivit...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  4,253 results

Dexamethasone-loaded H2O2-activatable anti-inflammatory nanoparticles for on-demand the...
https://doi.org/10.1016/j.nano.2020.102301
Nanomedicine : Nanotechnology, Biology, and Medicine; Lee H, Jeong SW et. al.

Sep 17th, 2020 - Asthma is a common airway inflammatory disorder, characterized by increased infiltration of leukocytes and bronchoconstriction. Dexamethasone (DEX) has been widely used in the treatment of allergic asthma. However, long-term and frequent use of DE...

Biflavonoid-rich fraction from Daphne pseudomezereum var. koreana Hamaya exerts anti-in...
https://doi.org/10.1016/j.jep.2020.113386
Journal of Ethnopharmacology; Lee JW, Ryu HW et. al.

Sep 13th, 2020 - Daphne pseudomezereum var. koreana Hamaya is distributed in the Gangwon-do of South Korea and is traditionally used to treat chronic inflammatory diseases, including rheumatoid arthritis. We investigated the anti-inflammatory effect of biflavonoid...

A Novel Mutation in the IL6R Gene Identified in a Family with Asthma Patients.
https://doi.org/10.1089/gtmb.2020.0081
Genetic Testing and Molecular Biomarkers; Trueb B, Zhuang L et. al.

Sep 10th, 2020 - Background: Allergic diseases, including asthma, atopic dermatitis, allergic rhinitis, and food allergies, are caused by both environmental and genetic factors. The allergic condition, where genetic factors make up the largest proportion (up to 95...

IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism and ...
https://doi.org/10.1016/j.jaci.2020.08.024
The Journal of Allergy and Clinical Immunology; Howard E, Lewis G et. al.

Sep 9th, 2020 - ILC2s are the dominant innate lymphoid cell population in the lungs at steady state and their release of type 2 cytokines is a central driver in responding eosinophil infiltration and increased airway hyperreactivity (AHR). Our laboratory has iden...

Vagal-α7nAChR signalling attenuates allergic asthma responses and facilitates asthma to...
https://doi.org/10.1111/imcb.12400
Immunology and Cell Biology; Feng X, Li L et. al.

Sep 7th, 2020 - Disorders of immune tolerance may lead to allergic asthma. Innate lymphoid cells (ILC2s) and inflammatory ILC2s (iILC2s) are key players in asthma. The vagus nerve innervating the airways releases acetylcholine (ACh) or neuropeptides (i.e. CGRP) v...

see more →

News  25 results

Eosinophilic Asthma | Apfed
https://apfed.org/about-ead/eosinophilic-asthma/

Jun 25th, 2018 - For decades physicians have understood that a diagnosis of asthma requires further description because attacks of wheezing and shortness of breath can be associated with several underlying diseases. For example, patients allergic to animal dander,...

Omalizumab Helps Relieve Food Allergies
https://www.mdedge.com/fedprac/article/157764/hospital-medicine/omalizumab-helps-relieve-food-allergies
Jan Dyer

Feb 6th, 2018 - More than 80% of children who were given omalizumab with oral immunotherapy (OIT) for 36 weeks could safely consume portions of at least 2 foods they were causing an allergic reaction, according to findings from a phase 2 study funded by the Natio.

Innovative Therapies for Severe Asthma
https://www.mdedge.com/fedprac/article/153356/pulmonology/innovative-therapies-severe-asthma/page/0/1

Dec 12th, 2017 - Biologic Agents Recent asthma research has been focused on disrupting the inflammatory cascade. Both GINA and ERS/ATS divide asthma into allergic vs nonallergic endotypes.

Omalizumab Offers Improvements in Patients with Asthma-COPD
https://www.medpagetoday.com/pulmonology/asthma/61298

Nov 8th, 2016 - Action Points Patients with severe allergic asthma and chronic obstructive pulmonary disease who received omalizumab (Xolair) showed improvements in asthma control and health-related quality of life. Note that the use of omalizumab, a recombinant ...

Steroid-sparing therapy is promising for allergic asthma
https://www.mdedge.com/pulmonary-health-hub/article/82306/pulmonology/steroid-sparing-therapy-promising-allergic-asthma
Bruce Jancin

May 12th, 2014 - KEYSTONE, COLO. – A novel toll-like receptor-9 agonist showed impressive clinical efficacy in persistent allergic asthma in a double-blind, placebo-controlled clinical trial.

see more →